# ClinicalTrials.gov record NCT00859534

> PeptideScanner retained ClinicalTrials.gov record NCT00859534 at 2026-07-30T22:26:45.018Z. Its registry update date was 2009-09-15, and PeptideScanner's reviewed identity mapping was afamelanotide.

- Evidence object: `story:clinicaltrials-gov-nct00859534-afamelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2009-09-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00859534-afamelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00859534-afamelanotide-v1.json
- Content SHA-256: `419fb3214b4795f2257f4bc8f22c00f50225a480cb84b558f8ff2576d591e0a6`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00859534 ([`ctg-observation-nct00859534-2009-09-15-a2c556624ec0`](#source-ctg-observation-nct00859534-2009-09-15-a2c556624ec0))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00859534 at 2026-07-30T22:26:45.018Z. Its registry update date was 2009-09-15, and PeptideScanner's reviewed identity mapping was afamelanotide. ([`ctg-observation-nct00859534-2009-09-15-a2c556624ec0`](#source-ctg-observation-nct00859534-2009-09-15-a2c556624ec0))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00859534 at 2026-07-30T22:26:45.018Z. Its registry update date was 2009-09-15, and PeptideScanner's reviewed identity mapping was afamelanotide. ([`ctg-observation-nct00859534-2009-09-15-a2c556624ec0`](#source-ctg-observation-nct00859534-2009-09-15-a2c556624ec0))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00859534-2009-09-15-a2c556624ec0`](#source-ctg-observation-nct00859534-2009-09-15-a2c556624ec0))

## Sources

<a id="source-ctg-observation-nct00859534-2009-09-15-a2c556624ec0"></a>
- **ClinicalTrials.gov record NCT00859534 · retained source version 2009-09-15:a2c556624ec0e9ed5ff95aca4c3d7f96c1ad0e4227302990571068b5773eb935** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00859534) (`ctg-observation-nct00859534-2009-09-15-a2c556624ec0`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00859534." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00859534-afamelanotide-v1.json SHA-256: 419fb3214b4795f2257f4bc8f22c00f50225a480cb84b558f8ff2576d591e0a6.